Amman Pharmaceutical Industries introduces new medical item
Al-Anbat - Dema Hina
Amman Pharmaceutical Industries announced the launch of a new medicinal item to treat eye dryness within Jordan and its export markets covering many countries around the world.
The new pharmaceutical item, called ClasGen, with a single-dose eye drop-shaped cyclosporine formula, joined the group of other items of 170 registered products produced by the company at its factory located in King Abdullah II Industrial City in Sahab.
The CEO and member of the company’s board of directors, Dr. Fadi Al-Atrash, said during a ceremony held on Sunday evening that the new drug formulation has been approved by the US Food and Drug Administration for the treatment of dry eye syndrome.
He added that the company, which was founded in 1989, is keen to keep up with pharmaceutical developments and produce treatments that serve the Kingdom, advance the Jordanian pharmaceutical industry, meet the requirements, and ensure patient safety.
He pointed out that the company is always striving to contribute to achieving medical security in line with His Majesty King Abdullah II’s continuous directives for self-reliance, support, and provision of vital medicines to serve citizens.
According to Dr. Al-Atrash, the company’s exports reached 30 countries distributed over the Middle East, Africa, Central Asia, North America , and Europe, while the company’s factory is built on an area of 5,000 square meters, in addition to multiple warehouses laboratories.
He pointed out that the company, which specializes in providing specialized treatments for the eyes, nose, and respiratory system, has provided 270 job opportunities for Jordanians, 55 percent of whom are females. It has scientific offices in many Arab countries and relies on solar energy for its production processes.
Al-Atrash indicated that the company has 8 production lines, producing 40 million units annually, and has a future plan to expand its investments inside the Kingdom, and focuses a lot on social responsibility and governance.
He emphasized that Jordan provides business owners with an attractive and investment- encouraging environment, with continuous royal and official support for the industry, in addition to the availability of competencies, qualified manpower, and various trade agreements with many countries.
Dr. Al-Atrash, who is also the representative of the medical industries and medical supplies sector at the Jordan Chamber of Industry, called for the importance of supporting the local pharmaceutical industry, which is considered the oldest in the region, and whose products have reached the world level thanks to its quality and competitiveness, in addition to the role of companies and factories in providing job opportunities and supporting the national economy.
During the ceremony, which was attended by a crowd of ophthalmologists and specialists in the Kingdom, a consultant ophthalmologist, Dr. Khaled Ayesh, delivered a scientific lecture to raise awareness of the uses of the new treatment produced by Amman Pharmaceutical Industries.